Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
about
An evidence based review of acute and long-term effects of cannabis use on executive cognitive functionsHuman cannabinoid pharmacokineticsQuantification and comparison of marijuana smoking practices: blunts, joints, and pipesAcute and non-acute effects of cannabis on brain functioning and neuropsychological performance.Temporal indication of cannabis use by means of THC glucuronide determination.Marijuana as doping in sports.Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections.Crash culpability relative to age and sex for injured drivers using alcohol, marijuana or cocaine.Bupropion reduces some of the symptoms of marihuana withdrawal in chronic marihuana users: a pilot studyNonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects.Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.Cannabis and sport.Estimating community drug abuse by wastewater analysis.Cannabis in sport: anti-doping perspective.Postmortem diagnosis and toxicological validation of illicit substance use.Mass spectrometric analysis of illicit drugs in wastewater and surface water.A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabisExtended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges.Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.Illicit drug consumption estimated by wastewater analysis in different districts of Milan: A case study.Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.Why should Cannabis be Considered Doping in Sports?Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletesMobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking.Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.Pharmacokinetics of 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol (CTHC) After Intravenous Administration of CTHC in Healthy Human Subjects
P2860
Q24627250-486768B7-868E-4837-A6BA-29DB7BA4D572Q24652736-58E37165-0BCE-4F93-A836-8526BFCC7DF5Q34511268-4EDDF0DF-9F18-42C5-BF47-8CEE77F0AA50Q34581675-681EA882-3216-4F54-9E2A-898433ABD342Q34618371-5DDB9886-7432-4C18-A70D-69053369B94DQ35126610-FE6E504C-E24B-45F9-9FE4-20D5A4310EF4Q35175102-685EFF6D-ADE0-4287-B7ED-9DD39F60F69AQ35553746-14B50D2B-DA75-4F38-9B28-A529D4C82510Q36139062-E7C0BA69-00CA-44B3-BAA2-F98DA40E3ED9Q36232377-2E085D7D-D40D-4528-BBB0-6B2826875BFCQ36288375-D63932B6-BE0E-4F31-B1DF-ABF324DCE40BQ36518625-9C3495ED-6A81-46A1-BE5B-8C491B8E3B18Q36838252-E41FB20E-120A-4328-B704-E6A5ED0D8990Q37029485-2EE94185-55A4-4DAF-8F7D-AAC682B0B995Q37091603-8A90FE12-4FAD-41DE-B10A-65B6D38A006CQ37141854-51030515-D741-4AFA-BD30-AAE17B36AD8FQ37235187-91A226D0-BA9C-4AEC-BC23-49B2B79C8E4AQ37389692-09D5CCD3-B2AD-407C-B564-F375A65AB0A6Q37810239-EB09CA06-A541-4DF7-A925-85609E01B97FQ38669813-55CAAB74-9599-4A06-80E7-310549088CCFQ40246359-0D3CBB8F-8682-411A-A1CD-DBE34CEBE0DCQ40669944-5AE0EBC7-3FE8-4404-BD10-429583D11740Q40714329-E41FE2FA-C12E-4201-B6E0-86D3FB402929Q43181133-EE165DC8-CE9D-48A5-A3C5-33A4AFAAD04DQ47266071-0BE0DFCC-652E-4A99-8502-78FB4968B456Q47558815-C607A337-BB45-44AB-A315-8CC0C03ADF90Q55263683-467FE03C-475A-437E-B052-1E11B33FF687Q56832278-BA9FF300-AFD9-4696-97B0-F5B03B42F4FD
P2860
Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Urinary excretion profiles of ...... gle smoked doses of marijuana.
@en
Urinary excretion profiles of ...... gle smoked doses of marijuana.
@nl
type
label
Urinary excretion profiles of ...... gle smoked doses of marijuana.
@en
Urinary excretion profiles of ...... gle smoked doses of marijuana.
@nl
prefLabel
Urinary excretion profiles of ...... gle smoked doses of marijuana.
@en
Urinary excretion profiles of ...... gle smoked doses of marijuana.
@nl
P2093
P356
P1476
Urinary excretion profiles of ...... gle smoked doses of marijuana.
@en
P2093
P304
P356
10.1093/JAT/20.6.441
P577
1996-10-01T00:00:00Z